185 related articles for article (PubMed ID: 16155030)
1. Targeting histones and proteasomes: new strategies for the treatment of lymphoma.
O'Connor OA
J Clin Oncol; 2005 Sep; 23(26):6429-36. PubMed ID: 16155030
[TBL] [Abstract][Full Text] [Related]
2. New drugs for the treatment of advanced-stage diffuse large cell lymphomas.
O'Connor OA; Hamlin P
Semin Hematol; 2006 Oct; 43(4):251-61. PubMed ID: 17027659
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mantle cell lymphoma: targeting the microenvironment.
Drach J; Seidl S; Kaufmann H
Expert Rev Anticancer Ther; 2005 Jun; 5(3):477-85. PubMed ID: 16001955
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of bortezomib in the treatment of indolent non-Hodgkin's and mantle cell lymphomas.
O'Connor OA
Curr Treat Options Oncol; 2004 Aug; 5(4):269-81. PubMed ID: 15233904
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma in relapse: the role of emerging new drugs.
Diefenbach CS; O'Connor OA
Curr Opin Oncol; 2010 Sep; 22(5):419-23. PubMed ID: 20679769
[TBL] [Abstract][Full Text] [Related]
8. Predicting the outcome in non-Hodgkin lymphoma with molecular markers.
Kwong YL
Br J Haematol; 2007 May; 137(4):273-87. PubMed ID: 17408399
[TBL] [Abstract][Full Text] [Related]
9. The role of bortezomib in the treatment of lymphoma.
Barr P; Fisher R; Friedberg J
Cancer Invest; 2007 Dec; 25(8):766-75. PubMed ID: 18058474
[TBL] [Abstract][Full Text] [Related]
10. Emerging therapies for B-cell non-Hodgkin lymphoma.
Briones J
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1305-16. PubMed ID: 19761434
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma: advances in biology and therapy.
Smith MR
Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
[TBL] [Abstract][Full Text] [Related]
12. New drugs for the treatment of lymphoma.
Paoluzzi L; Kitagawa Y; Kalac M; Zain J; O'Connor OA
Hematol Oncol Clin North Am; 2008 Oct; 22(5):1007-35, x. PubMed ID: 18954749
[TBL] [Abstract][Full Text] [Related]
13. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.
Jares P; Colomer D; Campo E
Nat Rev Cancer; 2007 Oct; 7(10):750-62. PubMed ID: 17891190
[TBL] [Abstract][Full Text] [Related]
14. Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future.
Cairo MS; Raetz E; Lim MS; Davenport V; Perkins SL
Pediatr Blood Cancer; 2005 Nov; 45(6):753-69. PubMed ID: 15929129
[TBL] [Abstract][Full Text] [Related]
15. Beyond monoclonal antibodies: new therapeutic agents in non-Hodgkin's lymphomas.
Delmonte A; Ghielmini M; Sessa C
Oncologist; 2009 May; 14(5):511-25. PubMed ID: 19411316
[TBL] [Abstract][Full Text] [Related]
16. Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma.
Winter JN
Curr Opin Hematol; 2007 Jul; 14(4):360-8. PubMed ID: 17534162
[TBL] [Abstract][Full Text] [Related]
17. Use of bortezomib in B-cell non-Hodgkin's lymphoma.
Wang M; Zhou Y; Zhang L; Nguyen CA; Romaguera J
Expert Rev Anticancer Ther; 2006 Jul; 6(7):983-91. PubMed ID: 16831071
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
19. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Collins-Burow B; Santos ES
Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies.
Obrador-Hevia A; Fernández de Mattos S; Villalonga P; Rodríguez J
Blood Rev; 2009 Sep; 23(5):205-16. PubMed ID: 19362399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
